MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The volume of STN tissue activated by DBS and the strength of its structural connectivity with SMA predicts the effects of STN-DBS on response inhibition

    G. Meyer, M. Albares, S. Thobois, E. Broussolle, G. Polo, P. Baraduc, B. Ballanger, ML. Welter, B. Lau, P. Boulinguez (Bron, France)

    Objective: To test the hypothesis that antidromic activation of the hyperdirect pathway might mediate the effects of STN-DBS on movement initiation control. Background: In PD,…
  • MDS Virtual Congress 2021

    Emotional and cognitive information processing in obstacle negotiation in patient with Parkinson’s disease and freezing

    S. Mezzarobba, M. Grassi, E. Pelosin, P. Manganotti, P. Bernardis (Genova, Italy)

    Objective: We used emotional (images from the International Affective Picture System - IAPS)1 and cognitive inputs(visual perturbation in a stepping-over-the-obstacle task) with the aim to…
  • MDS Virtual Congress 2021

    Sex-Specific White Matter Correlates of Neuropsychological Measures in Parkinson’s disease with Mild Cognitive Impairment

    V. Mishra, K. Sreenivasan, D. Cordes, A. Ritter, Z. Mari, J. Caldwell (Las Vegas, USA)

    Objective: To identify sex-specific white-matter (WM) correlates of neuropsychological measures in Parkinson’s disease (PD) with mild cognitive impairment (MCI). Background: Neuropsychological measures of executive function…
  • MDS Virtual Congress 2021

    Cognitive Diagnostics for Parkinson’s Disease: A Novel Digitized Approach Using Non-Motor Symptoms

    A. Murrar, M. Abu Snineh, M. Herzallah (Jerusalemp, State of Palestine)

    Objective: To evaluate the validity and reliability of cognitive markers to identify patients with PD Background: Parkinson’s disease (PD) is classically diagnosed by the clinical…
  • MDS Virtual Congress 2021

    Cognitive Impairment in Parkinson’s disease Patients: a Descriptive Study

    R. Nindela, A. Kurniawan, Y. Harun, S. Marisdina, I. Irfannuddin (Palembang, Indonesia)

    Objective: This study aims to describe the cognitive profile in Parkinson's disease (PD) patients. Background: Cognitive impairment is a common non-motor symptom of PD. Cohort…
  • MDS Virtual Congress 2021

    Dissociable contribution of serum NfL and p-tau181 to cognitive impairment and mild cognitive impairment in Parkinson’s disease.

    J. Pagonabarraga, R. Pérez-González, H. Bejr-Kasem, A. Horta-Barba, I. Aracil-Bolaños, S. Martinez-Horta, E. Rivas-Asensio, J. Perez-Perez, F. Sampedro, A. Campolongo, C. Izquierdo, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To analyze the contribution of serum NfL and p-tau181 levels to cognitive impairment and mild cognitive impairment (PD-MCI) in non-demented PD patients. Background: Autopsy…
  • MDS Virtual Congress 2021

    The retrograde procedural memory in people with Parkinson’s disease with or without freezing of gait – a cross-sectional study.

    L. Pauly, A. Rauschenberger, C. Pauly, M. Hansen, L. Pavelka, A. Hanff, V. Schröder, A. Leist, R. Krüger (Esch-Sur-Alzette, Luxembourg)

    Objective: To investigate the retrograde procedural memory in people with typical Parkinson’s disease (PwP) with or without freezing of gait (FOG). We hypothesized that the…
  • MDS Virtual Congress 2021

    Comparisons Between Parkinson’s Disease Patients and At-Risk Individuals: Can Olfactory Deficits and Cognitive Measures Serve as Preclinical Markers?

    L. Pimer, J. Fisk, M. Khan, R. Mckelvey, H. Robertson, T. Rolheiser, K. Schoffer, K. Good (Halifax, Canada)

    Objective: To examine whether individuals at increased risk of developing Parkinson’s disease (PD) show specific cognitive impairments suggestive of progression towards PD. Background: Olfactory deficits…
  • MDS Virtual Congress 2021

    Low dose trihexyphenidyl use causes cognitive dysfunction in Parkinson’s disease patients.

    L. Popil, M. Gavriliuc, A. Andrusca, O. Gavriliuc (Chisinau, Republic of Moldova)

    Objective: Evaluate cognitive performance in Parkinson's disease patients receiving a low dose of trihexyphenidyl (THP). Background: Before L-Dopa's discovery, anticholinergic drugs were among the first…
  • MDS Virtual Congress 2021

    Systematic review of cognitive subtypes derived from data driven approaches in Parkinson’s disease

    D. Pourzinal, J. Yang, R. Lawson, K. Mcmahon, G. Byrne, N. Dissanayaka (Herston, Australia)

    Objective: To consolidate the current literature pertaining to cognitive subtypes derived using data-driven methods in Parkinson’s Disease (PD). Background: Recent application of the Mild Cognitive…
  • « Previous Page
  • 1
  • …
  • 968
  • 969
  • 970
  • 971
  • 972
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley